Sonnet BioTherapeutics Holdings, Inc.
Pharmaceutical company · Princeton, New Jersey, United States
Sonnet BioTherapeutics Holdings, Inc. is a pharmaceutical company headquartered in Princeton, New Jersey, United States. It has reported private securities offerings to the US SEC, most recently $3.9 million sold in a notice filed in 2024.
Sonnet BioTherapeutics Holdings at a glance
What does Sonnet BioTherapeutics Holdings do?
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $3.9 million sold (2024).
Frequently asked questions about Sonnet BioTherapeutics Holdings
Where is Sonnet BioTherapeutics Holdings headquartered?
Sonnet BioTherapeutics Holdings, Inc. is headquartered in Princeton, New Jersey, United States.
What does Sonnet BioTherapeutics Holdings do?
Sonnet BioTherapeutics Holdings, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Similar companies
- Soligenix, Inc.Princeton, New Jersey, United States
- PDS Biotechnology CorpPrinceton, New Jersey, United States
- Enalare Therapeutics Inc.Princeton, New Jersey, United States
- Amicus Therapeutics, Inc.Princeton, New Jersey, United States
- Bristol Myers Squibb CoPrinceton, New Jersey, United States
- Grace Therapeutics, Inc.Princeton, New Jersey, United States
- PMV Pharmaceuticals, Inc.Princeton, New Jersey, United States
- Church & Dwight Co., Inc.Princeton, New Jersey, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences